心肌梗塞
观察研究
二级预防
BETA(编程语言)
经皮冠状动脉介入治疗
随机对照试验
心脏病学
内科学
冠状动脉疾病
医学
临床试验
心力衰竭
重症监护医学
计算机科学
程序设计语言
摘要
The benefit of beta-blockers after myocardial infarction was established before the advent of reperfusion and percutaneous coronary intervention and the availability of effective secondary preventive medications.1-3 Since these other treatments became accessible, the value of beta-blocker therapy in patients with coronary artery disease or myocardial infarction but without heart failure has been challenged. Observational studies have yielded conflicting results,4-6 and so far, only one small, open-label, randomized trial has been conducted, which showed no difference in clinical outcomes after 3 years.7 Yndigegn et al.8 now present in the Journal the results of the REDUCE-AMI trial (Randomized Evaluation of Decreased Usage . . .
科研通智能强力驱动
Strongly Powered by AbleSci AI